THE CHILDREN'S HOSPITAL OF PHILADELPHIA for THE CHILDREN'S HOSPITAL OF PHILADELPHIA
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicaid program reforms Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally H.R. 2107 (Childrens Hospital GME Support Reauthorization Act of 2025), all provisions Pediatric research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1509 / S. 752 (Accelerating Kids' Access to Care Act), all provisions Pediatric vaccine policy H.R. 1 (One Big Beautiful Bill Act) Infectious disease surveillance generally Pediatric autism research and treatment generally Pediatric telehealth policy generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| AHAVIAH DIANE GLASER | — |
| PETER GROLLMAN | — |
| SARAH GUERRIERI | — |
Budget/Appropriations BUD
Fiscal Year 2026 and 2027 Department of Health and Human Services funding, regarding National Institutes of Health funding, Childrens Hospital Graduate Medical Education (CHGME) program, Centers for Disease Control, and other programs related to pediatric health care Funding for cell and gene therapy generally Funding for Medicaid for children generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| AHAVIAH DIANE GLASER | — |
| PETER GROLLMAN | — |
| SARAH GUERRIERI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.